Drugs for treating acute respiratory distress syndrome (ARDS) in critically ill patients
What is this? Some patients with COVID-19 will develop acute respiratory distress syndrome (ARDS) and need help with their breathing. ARDS is caused by direct or indirect injury to the lungs and about 40% of people with ARDS will die. It is usually managed in an intensive care unit (ICU), sometimes...
| Autor principal: | |
|---|---|
| Formato: | Published Article |
| Publicado: |
2020-03-16
|
| Materias: | |
| Acceso en línea: | https://www.evidenceaid.org/drugs-for-treating-acute-respiratory-distress-syndrome-ards-in-critically-ill-patients https://hdl.handle.net/20.500.12663/776 |